Xiao Xu

2021- California NanoSystems Institute University of California, Los Angeles, Los Angeles, CA 
"Xiao Xu"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Luo L, Wang X, Liao YP, et al. (2023) Reprogramming the pancreatic cancer stroma and immune landscape by a silicasome nanocarrier delivering nintedanib, a protein tyrosine kinase inhibitor. Nano Today. 54
Xu X, Xia T. (2023) Recent Advances in Site-Specific Lipid Nanoparticles for mRNA Delivery. Acs Nanoscience Au. 3: 192-203
Xu X, Wang X, Liao YP, et al. (2023) Use of a Liver-Targeting Immune-Tolerogenic mRNA Lipid Nanoparticle Platform to Treat Peanut-Induced Anaphylaxis by Single- and Multiple-Epitope Nucleotide Sequence Delivery. Acs Nano
Shen S, Li T, Fan J, et al. (2022) Lipid-polymer hybrid nanoparticle with cell-distinct drug release for treatment of stemness-derived resistant tumor. Acta Pharmaceutica Sinica. B. 13: 1262-1273
Wang Q, Chen C, Xu X, et al. (2022) APAF1-Binding Long Noncoding RNA Promotes Tumor Growth and Multidrug Resistance in Gastric Cancer by Blocking Apoptosome Assembly. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2201889
Shen S, Lin S, Chen Y, et al. (2022) Combating Cancer Stem-Like Cell-Derived Resistance to Anticancer Protein by Liposome-Mediated Acclimatization Strategy. Nano Letters
Jiang T, Ma Y, Xu X, et al. (2021) Enzyme-instructed hybrid nanogel/nanofiber oligopeptide hydrogel for localized protein delivery. Acta Pharmaceutica Sinica. B. 11: 2070-2079
Jiang T, Liu C, Xu X, et al. (2021) Formation Mechanism and Biomedical Applications of Protease-Manipulated Peptide Assemblies. Frontiers in Bioengineering and Biotechnology. 9: 598050
Cai Y, Bing W, Xu X, et al. (2021) Topographical nanostructures for physical sterilization. Drug Delivery and Translational Research
Shen S, Xu X, Lin S, et al. (2021) A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells. Nature Nanotechnology. 16: 104-113
See more...